UBS

UBS Group
D

UBS

Arincen57/100B

UBS Group return on equity (ROE)

UBS Group's return on equity is 10.02%: net income of 8.88B USD over the last twelve months on shareholders' equity of 88.61B USD.

Today
10.02%
Average, 5 years
15.41%
Low, 5 years
2.33%
High, 5 years
36.52%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 8.88B ÷ 88.61B = 10.02%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

What drives UBS Group's return on equity?

Net margin
10.5%
profit on each dollar of sales
Asset turnover
0.05×
sales on each dollar of assets
Equity multiplier
17.93×
assets on each dollar of equity
Return on equity
8.6%
FY2025
  • FY202510.5% × 0.05 × 17.93 = 8.6%
  • FY20246.2% × 0.05 × 18.39 = 5.4%
  • FY202340.8% × 0.03 × 19.94 = 27.2%
  • FY202219.2% × 0.03 × 19.42 = 12.4%
  • FY202119.5% × 0.03 × 18.42 = 11.2%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today10.02%8.88B88.61B
FY202531 Dec 20256.86%6.18B90.21B
FY202431 Dec 20246.05%5.15B85.08B
FY202331 Dec 202332.36%27.87B86.11B
FY202231 Dec 202213.47%7.66B56.88B
FY202131 Dec 202112.34%7.49B60.66B
FY202031 Dec 202011.06%6.57B59.45B
FY201931 Dec 20197.91%4.31B54.50B
FY201831 Dec 20188.54%4.52B52.93B
FY201731 Dec 20172.21%1.16B52.50B
FY201631 Dec 20166.10%3.23B52.92B
FY201531 Dec 201511.55%6.46B55.96B
FY201431 Dec 20147.19%3.68B51.18B
FY201331 Dec 20137.04%3.81B54.09B
FY201231 Dec 2012-4.86%-2.45B50.33B
FY201131 Dec 20119.12%4.70B51.57B
FY201031 Dec 201017.07%7.99B46.78B
FY200931 Dec 2009-5.18%-2.05B39.63B
FY200831 Dec 2008-62.46%-18.98B30.38B
FY200731 Dec 2007-10.42%-3.39B32.54B
FY200631 Dec 200625.64%10.45B40.77B
FY200531 Dec 200533.38%11.18B33.50B
FY200431 Dec 200423.12%7.09B30.65B
FY200331 Dec 200318.02%5.15B28.59B
FY200231 Dec 20029.07%2.56B28.23B
FY200131 Dec 200111.42%3.00B26.27B
FY200031 Dec 200017.38%4.83B27.78B
FY199931 Dec 199920.58%3.96B19.22B

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Debt to equity,Current ratio,All ratios

Common questions about UBS Group's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.